Selecta Biosciences - Company & Market Research Reports

Selecta Biosciences was founded in 2007 and is headquartered in Watertown, Massachusetts. It is a biopharmaceutical company, they create biological therapies that fight against unwanted immune responses. Selecta Biosciences specialise in Synthetic Vaccine Particles (SVP™) technology platform. They use this treatment to fight rare and serious diseases. Selectas current pipeline includes: SVP- enabled enzyme, oncology and gene therapies.

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

  • Report
  • 265 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
2018 Celiac (Coeliac) Disease Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Celiac (Coeliac) Disease Drug Development- Pipeline Analysis Report

  • Report
  • 63 Pages
From
Gouty Arthritis (Gout) - Pipeline Review, H1 2018 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H1 2018

  • Report
  • 99 Pages
From
Diabetes & Obesity Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • Report
  • 560 Pages
From
Global Smoking Cessation Drugs Market 2016-2020 - Product Thumbnail Image

Global Smoking Cessation Drugs Market 2016-2020

  • Report
  • 74 Pages
From
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2018 - Product Thumbnail Image

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2018

  • Report
  • 38 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Human Papillomavirus Protein E6 (E6) - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H1 2018

  • Report
  • 81 Pages
From
Chlamydia Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Chlamydia Infections - Pipeline Review, H1 2018

  • Report
  • 71 Pages
From
Chlamydia Infections - Pipeline Insight, 2018 - Product Thumbnail Image

Chlamydia Infections - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Report
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Report
  • 1020 Pages
From
Celiac Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Celiac Disease - Pipeline Review, H1 2018

  • Report
  • 83 Pages
From
Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016 - Product Thumbnail Image

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

  • Report
  • 104 Pages
From
Cervical Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H1 2018

  • Report
  • 768 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Report
  • 2509 Pages
From
Smoking Addiction - Pipeline Review, H2 2017 - Product Thumbnail Image

Smoking Addiction - Pipeline Review, H2 2017

  • Report
  • 89 Pages
From
Smoking Addiction - Pipeline Review, H1 2017 - Product Thumbnail Image

Smoking Addiction - Pipeline Review, H1 2017

  • Report
  • 86 Pages
From
Peanut Allergy - Competitive Landscape, Market Insights, Epidemiology and Market Forecast 2025 - Product Thumbnail Image

Peanut Allergy - Competitive Landscape, Market Insights, Epidemiology and Market Forecast 2025

  • Drug Pipelines
  • 163 Pages
From
Loading Indicator
adroll